Clinical Trial

A Geriatric Mobile Team for Nursing Home Residents: a Feasibility Pilot Study

Study acronym: GerMoT
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated February 28, 2026 completion). Its status may not reflect the trial's current state.
Summary
Nursing home (NH) residents have complex healthcare needs. Barriers to collaboration hinder the delivery of high-quality care in nursing homes. To bridge the gap between hospital-based and NH-based care, various innovative approaches have been proposed, including geriatric mobile teams. In Belgium, geriatric expertise has long been confined to hospital settings. Until recently, no specific organization existed for outpatient geriatric assessment, particularly for NH residents. In April 2024, the National Institute for Health and Disability Insurance (INAMI) introduced a new reimbursement code for geriatric consultations in NHs, promoting the development of extramural geriatric activities. However, evidence on the effectiveness of mobile geriatric teams remains limited, particularly regarding hospitalization prevention. The geriatrics department of CHU UCL Namur is implementing a one-year pilot project involving a mobile team composed of a geriatrician and a nurse to conduct geriatric assessments in the three nursing homes. This non-randomized pilot project aims to establish a new standard of care for residents selected by their general practitioner, leveraging the new reimbursement code. The project is accompanied by a clinical study assessing the feasibility, effectiveness, and acceptability of this intervention. Prospectively collected data will also help define key indicators for a future large-scale study focused on cost-effectiveness.
Trial Details
NCT Number NCT06873919
Lead Sponsor Université Catholique de Louvain
Collaborators: Centre Hospitalier Universitaire UCLouvain Namur
Conditions Nursing Home Resident, Geriatric Assessment
Enrollment 200 participants
Start Date 2025-03-05
Primary Completion 2026-02-28 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-03-13